discontinued

bs-9740R CNTD2 antibody

See related secondary antibodies

Search for all "CNTD2"

0.1 ml / €240.00

Quick Overview

Rabbit anti Human CNTD2

bs-9740R

Product Description for CNTD2

Rabbit anti Human CNTD2.
Presentation: Purified
Product is tested for Paraffin Sections.

Properties for CNTD2

Product Category Primary Antibodies
Quantity 0.1 ml
Synonyms CNTD 2, CNTD-2, CNTD2, CNTD2_HUMAN., Cyclin N terminal domain containing 2, Cyclin N terminal domain containing protein 2, FLJ13265
Presentation Purified
Reactivity Hu
Applications P
Clonality Polyclonal
Host Rabbit
Isotype IgG
Shipping to Europe only
PDF datasheet View Datasheet
Manufacturer Bioss, Inc.

Datasheet Extract

Immunogen
Swiss Prot Num:
B4DX65
Immunogen:
KLH conjugated synthetic peptide derived from human CNTD2.
GeneID:
79935
Application IHC-P(1:100-500)
IF(IHC-P)(1:50-200)
Background CNTD2 (cyclin N-terminal domain containing 2) is a 155 amino acid protein that contains one cyclin N-terminal domain and is encoded by a gene that maps to human chromosome 19q13.2. Chromosome 19 consists of approximately 63 million bases and makes up over 2% of human genomic DNA. Chromosome 19 is recognized for having the greatest gene density of the human chromosomes. It is the genetic home for a number of immunoglobulin superfamily members, including killer cell and leukocyte Ig-like receptors, various ICAMs, the CEACAM and PSG families, and Fc?receptors. Key genes for eye color and hair color also map to chromosome 19. Peutz-Jeghers syndrome, spinocerebellar ataxia type 6, the stroke disorder CADASIL, hypercholesterolemia and insulin-dependent diabetes have been linked to chromosome 19. Translocations with chromosome 19 and chromosome 14 can be seen in some lymphoproliferative disorders and typically involve the proto-oncogene Bcl-3.
Storage Store at -20°C for 12 months.
Format
Purification:
Purified by Protein A.
Buffer System:
Aqueous buffered solution containing 100ug/ml BSA, 50% glycerol and 0.09% sodium azide.
State:
Purified

Accessory Products

  • LinkedIn